OMX30 1 645 0,2%  OMXH25 4 061 -0,6%  OMXC20 1 014 0,0%  Dow 21 399 0,0%  Nas 5 801 0,4%  EUR 9,7619 0,0%  USD 8,7185 -0,4%  Olja 45,3 0,1%  Guld 1 256 -0,3% 

Johnson & Johnson Aktie

135,69USD -0,37USD -0,27%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,35 3,56 3,80 3,90
Direktavkastning (i %) 2,71 2,48 2,63 2,81 2,88
PE-tal 17,24 19,02 17,66 16,62 15,64
Resultat/aktie 6,73 7,10 7,65 8,13 8,64
ytterligare nyheter

Analyser om Johnson & Johnson

ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 0,00
0,0%
Alexion Pharmaceuticals 0,00
0,0%
AstraZeneca 0,00
0,0%
Bayer 0,00
0,0%
Beiersdorf 0,00
0,0%
Celgene 0,00
0,0%
Fresenius Medical Care 0,00
0,0%
Fresenius 0,00
0,0%
GlaxoSmithKline 0,00
0,0%
Johnson & Johnson 0,00
0,0%
Merck 0,00
0,0%
Merck 0,00
0,0%
MorphoSys 0,00
0,0%
Nestlé 0,00
0,0%
Novartis 0,00
0,0%
Pfizer 0,00
0,0%
Procter & Gamble 0,00
0,0%
Roche 0,00
0,0%
STADA 0,00
0,0%
Sanofi 0,00
0,0%
Unilever 0,00
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnsontill bolagsprofilen

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
135,66
USD
Ask
135,67
USD
Kurstid
19:21
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 135,69 USD -0,37 -0,27 %
Kurstid 19:21:54
Datum 23.06.2017
Öppning 135,45
Gårdagen 136,06
Dagshögsta 136,05
Dagslägsta 135,35
52 v. högsta 137,00
52 v. lägsta 109,33
52 v. perf.
Volym (Antal) 166 167
Börsvärde (SEK) 3 226,12 Mrd
Börsen
Kurs för 135,69 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 183,01 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index S&P 500, Dow Jones, BX Swiss - USA, S&P 100, NYSE US 100

Johnson & Johnson Nyckeltal

Börsvärde i SEK 3 226,12 Mrd
Free float % 99,90
Antal aktier mio. 2 693,83
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,43
60 dagar vola 11,23
PBV 4,23

Johnson & Johnson Historiska kurser

2017-06-22 136,06 334 106
2017-06-21 134,94 400 432
2017-06-20 134,23 321 893
2017-06-19 134,04 385 718
2017-06-16 134,36 350 389

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 316,3 %
Immunomedics Inc. 276,9 %
Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
EXACT Sciences Corp. 253,2 %